Last reviewed · How we verify
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot (SUBQ-Pilot)
The Pilot study is designed to evaluate the overall safety and feasibility of a strategy based on subcutaneous delivery of furosemide. It will be used to inform the subsequent evaluation phase of the study (separate protocol). The primary objective of the study is to determine if a strategy of a novel subcutaneous delivery of furosemide is safe and feasible in patients with acute heart failure.
Details
| Lead sponsor | Adrian Hernandez |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 40 |
| Start date | Mon Dec 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Acute Heart Failure
Interventions
- Furosemide
Countries
United States